Search CommunityWalk:


Theranostics Health

15010 Broschart Road
Rockville, MD 20850, USA

Category: Bioinformatics/Genomics/Proteomics/Pharmacogenomics

Used in the following map:

Maryland Biotech Industry Map

Theranostics Health is engaged in the development and commercialization of proprietary, proteomic-based services and discoveries that are intended for the treatment of patients with diseases such as cancer. It was established in 2006.

Theranostics' core technology includes: Reverse Phase Protein Microarray (RPMA) and Laser Capture Microdissection (LCM). Its technology measures the activity of a large number of biomarkers, enabling pharmaceutical companies to accurately profile their drug candidates to facilitate efficient and effective drug development. Its uses Laser Capture Microdissection (LCM) to isolate a specific cellular population from cellular components normally existing in a clinical biopsy, which is essential to generate correct pathway activation portraits in specific cellular samples.

Theranostics also uses Reverse Phase Protein Microarray (RPMA) which enables sensitive, non-subjective, quantitative, calibrated, multiplexed analysis of cellular proteins from a limited amount of starting sample, such as clinical specimens. Its services provide specific solutions which include: proprietary molecular fixation, analysis of various sample types, isolation of specific cells of interest through Laser Capture Microdissection (LCM) etc.

Theranostics Health has collaborations with Duke University and National Institutes of Health.